Telemedicine in outpatient diabetes practice
Authors:
Jozef Lacka 1; Barbora Lacková 1,2; Linda Ilavská 3,4; Adriana Ilavská 3
Authors‘ workplace:
JAL, s. r. o., Trnava
1; 2. LF UK, Praha
2; Medispektrum, s. r. o., Bratislava
3; LF UK v Bratislave
4
Published in:
Forum Diab 2024; 13(1): 6-15
Overview
Diabetes mellitus (DM) is a chronic, progressive, lifelong disease associated with regular visits at doctor. Monitoring measurements is one of the key factors in disease management and it is also an indicator of diabetic adherence and compliance of the patient. Patient is mostly willing to cooperate in the treatment at the beginning of the disease and in the first few months, after that it gradually weakens over the long term. In the study, we evaluated the data of 211 newly diagnosed patients with type 2 diabetes for a period of 11 months. In addition to the routine practice of personal visits of the doctor, we actively used the possibilities of telemedicine. During the first visit, patients received a telemedicine kit that includes glucometer, scale, blood pressure monitor, ECG and oximeter. The metabolic compensation was verified by evaluating glycated hemoglobin. By establishing telemedicine it enabled monitoring of compliance and adherence in the treatment of DM. The growing number of diabetics and the frequency of examinations puts pressure on the health system. In the management of patients with DM, tools for objectification are needed to continuously motivate patients. Telemedicine contributes to better compliance, adherence, metabolic compensation and reduces the need for frequent personal patient visits.
Keywords:
compliance – Telemedicine – diabetes mellitus – adherence – self-monitoring
Sources
Consolidated telemedicine implementation guide. World Health Organization: 2022. ISBN 978–92–4-005918–4. Dostupné z WWW: <https://iris.who.int/bitstream/handle/10665/364221/9789240059184-eng.pdf?sequence=1>.
Stanberry B. Legal and ethical aspects of telemedicine. J Telemed Telecare 2006; 12(4): 166–175. Dostupné z DOI: <http://dx.doi.org/10.1258/135763306777488825>.
Aberer F, Hochfellner DA, Mader JK. Application of Telemedicine in Diabetes Care: The Time is now. Diabetes Ther 2021; 12(3): 629–639. Dostupné z DOI: <https://doi.org/10.1007/s13300–020–00996–7>.
Dhediya R, Chadha M, Bhattacharya AD et al. Role of Telemedicine in Diabetes Management. J Diabetes Sci Technol 2023; 17(3): 775–781. Dostupné z DOI: <http://dx.doi.org/10.1177/19322968221081133>.
de Kreutzenberg SV. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations after COVID-19 Experience. High Blood Press Cardiovasc Prev 2022; 29(4): 319–326. Dostupné z DOI: <http://dx.doi.org/10.1007/s40292–022–00524–7>.
Michaud TL, Ern J, Scoggins D et al. Assessing the impact of telemonitoring-facilitated lifestyle modifications on diabetes outcomes: a systematic review and meta-analysis. Telemed J E Health 2021; 27(2): 124–136. Dostupné z DOI: <https://doi.org/10.1089/tmj.2019.0319>.
[American Diabetes Association]. 8. Obesity Management for the Treatment of Type 2 Diabetes: In: Standards of Medical Care in Diabetes – 2021. Diabetes Care 2021; 44(Suppl 1): S100–S110. Dostupné z DOI: <https://doi.org/10.2337/dc21-S008>.
Greenwood DA, Young HM, Quinn CC. Telehealth Remote Monitoring Systematic Review: Structured Self-monitoring of Blood Glucose and Impact on A1C. J Diabetes Sci Technol 2014; 8(2): 378–389. Dostupné z DOI: <http://dx.doi.org/10.1177/1932296813519311>.
Rodrigues CI. Self-Monitoring with or without Telemonitoring: Is a New Time for Diagnosis and Management Hypertension? Arq Bras Cardiol 2019; 113(5): 976–978. Dostupné z DOI: <http://dx.doi.org/10.36660/abc.20190701>.
Ramos-Zavala MG, Grover-Páez F, Cardona-Muñoz EG et al Comparison of the use of blood pressure telemonitoring versus standard medical care in the achievement of short-term therapeutic goals in blood pressure in patients with uncontrolled hypertension: An open-label clinical trial. JRSM Cardiovasc Dis 2023; 12: 20480040231178585. Dostupné z DOI: <http://dx.doi.org/10.1177/20480040231178585>.
Ufholz K, Bhargava D. A Review of Telemedicine Interventions for Weight Loss. Curr Cardiovasc Risk Rep 2021; 15(9): 17. Dostupné z DOI: <http://dx.doi.org/10.1007/s12170–021–00680-w>.
Harms PP, van der Heijden AA, Rutters F et al. Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort. J Diabetes Complications 2021; 35(2): 107810. Dostupné z DOI: <https://doi.org/10.1016/j.jdiacomp.2020.107810>.
Aboalseoud A, Youssry A, El-Nozahi M et al. Wireless ECG Monitoring System for Telemedicine Application. 2019 Ninth International Conference on Intelligent Computing and Information Systems (ICICIS). Cairo, Egypt 2019: 300–305. Dostupné z DOI: <http://dx.doi.org/10.1109/ICICIS46948.2019.9014845>
Alboksmaty A, Beaney T, Elkin S et al. Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19: a systematic review. Lancet Digit Health 2022; 4(4): E279–E289. Dostupné z DOI: <https://doi.org/10.1016/S2589–7500(21)00276–4>.
Vestník MZ SR 43/201.1 Odborné usmernenie na poskytovanie zdravotnej starostlivosti pacientom s diabetes mellitus. Dostupné z WWW: <https://www.epi.sk/vestnik-mzsr/2011–43>.
Alvarado MM, Kum HC, Gonzalez Coronado K et al. Barriers to remote health interventions for type 2 diabetes: a systematic review and proposed classification scheme. J Med Internet Res 2017; 19(2): e28. Dostupné z DOI: <http://dx.doi.org/10.2196/jmir.6382>.
Zhang X-Y, Zhang P. Telemedicine in clinical setting. Exp Ther Med 2016; 12(4): 2405–2407. Dostupné z DOI: <http://dx.doi.org/10.3892/etm.2016.3656>.
Zulman DM, Verghese A. Virtual Care, Telemedicine Visits, and Real Connection in the Era of COVID-19: Unforeseen Opportunity in the Face of Adversity. JAMA 2021; 325(5): 437–438. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2020.27304>.
Patel SY, Mehrotra A, Huskamp HA et al. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US. JAMA Intern Med 2021; 181(3): 388–391. Dostupné z DOI: <http://dx.doi.org/10.1001/jamainternmed.2020.5928>.
Lee JY, Chan CKY, Chua SS et al. Using telemedicine to support care for people with type 2 diabetes mellitus: a qualitative analysis of patients’ perspectives. BMJ Open 2019; 9(10): e026575. Dostupné z DOI: <http://dx.doi.org/10.1136/bmjopen-2018–026575>.
Farooqi MH, Abdelmannan DK, Al Buflasa MM et al. The Impact of Telemonitoring on Improving Glycemic and Metabolic Control in Previously Lost-to-Follow-Up Patients with Type 2 Diabetes Mellitus: A Single-Center Interventional Study in the United Arab Emirates. Int J Clin Pract 2022; 2022: 6286574. Dostupné z DOI: <http://dx.doi.org/10.1155/2022/6286574>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
2024 Issue 1
Most read in this issue
- Long term protective effects of empagliflozine in whole spectrum of patients with type 2 diabetes mellitus from early stages of disease
- New recommendations for arterial hypertension management and blood pressure targets for type 2 diabetes mellitus
- Folistatin and type 2 diabetes mellitus
- Telemedicine in outpatient diabetes practice